Omar Hasan Ali
University of Zurich(CH)Kantonsspital St. Gallen(CH)University Hospital of Zurich(CH)Albany Medical Center Hospital(US)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, CAR-T cell therapy research
Most-Cited Works
- → Association of Checkpoint Inhibitor–Induced Toxic Effects With Shared Cancer and Tissue Antigens in Non–Small Cell Lung Cancer(2019)383 cited
- → Human leukocyte antigen variation is associated with adverse events of checkpoint inhibitors(2018)178 cited
- → Association Between Immune-Related Adverse Events During Anti–PD-1 Therapy and Tumor Mutational Burden(2019)129 cited
- → Characterization of nivolumab-associated skin reactions in patients with metastatic non-small cell lung cancer(2016)116 cited
- → Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitors(2023)115 cited
- → A diabetic milieu increases ACE2 expression and cellular susceptibility to SARS-CoV-2 infections in human kidney organoids and patient cells(2022)109 cited